Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 76 Projects
Project # Contact PI Funding Organization Fiscal Year
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients with C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)
ADDF-35 Panzara, Michael Alzheimer's Drug Discovery Foundation 2021
MIB-626 For Treatment of Mild Dementia Patients
ADDF-43 Livingston, David Alzheimer's Drug Discovery Foundation 2021
Testing low-dose efavirenz treatment for Alzheimer’s disease: a phase 1b dosing, target-engagement and exploratory biomarker study.
ADDF-48 SCHELTENS, PHILIP Alzheimer's Drug Discovery Foundation 2021
A single-center, randomized, placebo-controlled single & multiple ascending dose study in healthy subjects to study the safety, tolerability, food effect, pharmacokinetics and target engagement of the second-generation O-GlcNAcase inhibitor ASN121151
ADDF-1 Beher, Dirk Alzheimer's Drug Discovery Foundation 2020
Phase II Clinical Trial to Evaluate the Safety and Feasibility of Senolytic Therapy in Alzheimer's Disease
ADDF-25 Orr, Miranda Alzheimer's Drug Discovery Foundation 2020
Phase I Clinical Trial for the AAV mediated treatment of APOE4 homozygous Alzheimer's Disease
ADDF-26 Crystal, Ronald Alzheimer's Drug Discovery Foundation 2020
Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical Adults
CLNA-001-15S Carlsson, Cynthia M. United States Department of Veterans Affairs (VA) 2020
Profiling Alzheimer's Biomarkers
NURD-022-16F WYSS-CORAY, TONY United States Department of Veterans Affairs (VA) 2020
TTI-0102, a Cysteamine Precursor for Mild to Moderate TBI: Dosing and Feasibility Study
RRDS-060-19S Twamley, Elizabeth United States Department of Veterans Affairs (VA) 2020
5th Annual Goodes Prize for Excellence in Alzheimer’s Drug Discovery: Rasagiline Rescue in Alzheimer’s Disease Clinical Trial (R2 Trial) – Biomarker add-on funding
GC-201908-2019444 Cummings, Jeffrey Alzheimer's Drug Discovery Foundation 2019